0.7962
전일 마감가:
$0.8635
열려 있는:
$0.81
하루 거래량:
1.59M
Relative Volume:
0.57
시가총액:
$49.99M
수익:
$11.03M
순이익/손실:
$-44.24M
주가수익비율:
-1.2842
EPS:
-0.62
순현금흐름:
$-42.61M
1주 성능:
+32.15%
1개월 성능:
+18.31%
6개월 성능:
-18.76%
1년 성능:
-10.54%
Hyperfine Inc Stock (HYPR) Company Profile
명칭
Hyperfine Inc
전화
866-796-6767
주소
351 NEW WHITFIELD STREET, GUILFORD
HYPR을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
HYPR
Hyperfine Inc
|
0.7962 | 46.63M | 11.03M | -44.24M | -42.61M | -0.62 |
![]()
ABT
Abbott Laboratories
|
133.58 | 231.14B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
102.09 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
383.89 | 146.12B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
87.44 | 105.64B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.52 | 45.60B | 5.54B | 4.18B | 623.10M | 7.00 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2022-08-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2022-05-31 | 개시 | Evercore ISI | Outperform |
2022-04-14 | 개시 | Wells Fargo | Overweight |
Hyperfine Inc 주식(HYPR)의 최신 뉴스
Hyperfine at Jefferies Healthcare: New MRI System Unveiled - Investing.com
Hyperfine trading spiked on algorithms caching ‘AI,’ says B. Riley - Yahoo Finance
Hyperfine Stock Rises After FDA Clears Next-Gen Swoop MRI System - sharewise
Hyperfine announces FDA clearance of Swoop system - MSN
Hyperfine Wins FDA Nod for Next-Gen Swoop MRI with Optive AI - Medical Product Outsourcing
Hyperfine unveils FDA-cleared next-gen portable MRI By Investing.com - Investing.com South Africa
Hyperfine unveils FDA-cleared next-gen portable MRI - Investing.com India
Hyperfine Stock Is Soaring Higher Monday: What's Going On? - Benzinga
Hyperfine wins FDA nod for next-gen Swoop powered by AI - MassDevice
Hyperfine (HYPR) Gains FDA Approval for New Portable MRI Scanner | HYPR Stock News - GuruFocus
Hyperfine Announces FDA Clearance Of A New Next-Generation Swoop System Powered By Optive Ai Software - marketscreener.com
Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality - Business Wire
Hyperfine Receives FDA Clearance of Optive AI Software - Imaging Technology News
Hyperfine unveils advanced AI software for portable MRI By Investing.com - Investing.com South Africa
Hyperfine Gets FDA Clearance For Optive AI Software, Marking Major Upgrade To Swoop MRI Imaging - Nasdaq
FDA OKs Hyperfine’s Optive AI Software for Swoop MR - Medical Product Outsourcing
Hyperfine Announces FDA Clearance Of Optive AI(TM) Software - marketscreener.com
Hyperfine announces FDA clearance of next-generation software - TipRanks
Hyperfine unveils advanced AI software for portable MRI - Investing.com India
Hyperfine (HYPR) Gains FDA Clearance for Advanced Imaging Softwa - GuruFocus
Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System - Business Wire
Hyperfine Chairperson R. Scott Huennekens Resigns - MSN
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Lags Revenue Estimates - MSN
Hyperfine Holds Annual Stockholders Meeting - TipRanks
B. Riley Has Optimistic Outlook of Hyperfine Q3 Earnings - Defense World
B. Riley Cuts Hyperfine (NASDAQ:HYPR) Price Target to $1.00 - Defense World
Here's Why Hyperfine (NASDAQ:HYPR) Must Use Its Cash Wisely - simplywall.st
Hyperfine Inc. Earnings Call: Transition and Growth - TipRanks
Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference - 01net
Hyperfine (HYPR) Maintained as 'Buy' by B. Riley Securities, Price Target Lowered | HYPR Stock News - GuruFocus
Hyperfine price target lowered to $1 from $1.20 at B. Riley - TipRanks
B. Riley Reduces Price Target for Hyperfine (HYPR) After Sales M - GuruFocus
B. Riley Lowers Price Target on Hyperfine to $1 From $1.20, Keeps Buy Rating - marketscreener.com
Hyperfine (HYPR) Maintained as 'Buy' by B. Riley Securities, Pri - GuruFocus
Hyperfine Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
Wells Fargo Updates Price Target and Rating for HYPR | HYPR Stoc - GuruFocus
Hyperfine (HYPR) Reports Lower Q1 Revenue, Optimistic About Futu - GuruFocus
Hyperfine, Inc. (NASDAQ:HYPR) Q1 2025 Earnings Call Transcript - Insider Monkey
Hyperfine’s net loss for Q1 2025 hits USD 9.4M - Medical Buyer
Hyperfine outlines 10%–20% revenue growth for 2025 as new product launches and office market entry drive diversification - MSN
Hyperfine Q1 2025 Earnings Call Transcript - MarketBeat
Hyperfine, Inc. Reports Q1 2025 Financial Results - TipRanks
Hyperfine reports Q1 EPS (12c), consensus (12c) - TipRanks
Earnings call transcript: Hyperfine Misses Q1 2025 Revenue Expectations By Investing.com - Investing.com Nigeria
Earnings call transcript: Hyperfine Misses Q1 2025 Revenue Expectations - Investing.com
Hyperfine Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Hyperfine Q1 2025 slides reveal portable MRI expansion strategy despite mixed results - Investing.com Australia
Hyperfine Q1 2025 slides reveal portable MRI expansion strategy despite mixed results By Investing.com - Investing.com South Africa
Hyperfine Inc (HYPR) Q1 2025 Earnings: EPS Meets Estimate at -$0 - GuruFocus
Hyperfine Inc Files For Offering Of Up To $50 Million Of Shares Of Class A Common Stock - marketscreener.com
Hyperfine, Inc. SEC 10-Q Report - TradingView
Hyperfine Inc (HYPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Hyperfine Inc 주식 (HYPR) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
TEISSEYRE THOMAS | Chief Operating Officer |
Feb 18 '25 |
Sale |
1.20 |
3,237 |
3,884 |
84,990 |
TEISSEYRE THOMAS | Chief Operating Officer |
Nov 18 '24 |
Sale |
0.85 |
2,800 |
2,380 |
88,227 |
TEISSEYRE THOMAS | Chief Operating Officer |
Aug 16 '24 |
Sale |
1.05 |
2,746 |
2,883 |
91,027 |
자본화:
|
볼륨(24시간):